[시장보고서]북미의 독성학 연구소 시장 : 북미의 업계 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2030년)

북미의 독성학 연구소 시장 : 북미의 업계 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2030년) - 약제 클래스별, 제품 유형별, 샘플별, 국가별, 기업별

North America Toxicology Laboratories Market - North America Toxicology Laboratories Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Drug Class, By Product Type, By Sample, By Geographic Coverage and By Company)

상품코드 : 1447964

리서치사 : Fairfield Market Research

발행일 : 2024년 03월

페이지 정보 : 영문 100 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,411,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495

￦ 12,604,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600

￦ 15,727,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

북미의 독성학 연구소 시장 규모는 예측기간 중 확실히 CAGR은 10.4%로 예측되며, 2023년 2억 5,520만 달러에서 2030년 말에는 5억 1,120만 달러로 급증할 것으로 예측됩니다.

시장 확대를 추진하는 주요 동향으로는 신속한 스크리닝 기술의 중요성이 높아지고 있는 것 등이 있습니다. 가스 크로마토그래피 질량 분석(GC-MS)과 같은 기술의 발전으로 독성학 연구소에서는 효율적인 스크리닝 방법에 대한 수요가 급증하고 소요 시간 및 감도가 향상되었습니다.

이 보고서에서 확인된 또 다른 중요한 동향은 독성학 연구소의 정보 과학 및 데이터 솔루션의 통합입니다. 민감한 검사 결과는 질량 분석 데이터베이스에 안전하게 저장되며 이 업계의 데이터 무결성과 민감성의 중요성을 강조합니다.

본 보고서에서는 북미의 독성학 연구소 시장에 대해 조사했으며, 시장 개요와 함께 약품 등급별, 제품 유형별, 샘플별, 국가별, 기업별 동향 및 시장 진출기업의 경쟁 동향 등을 제공합니다.

북미의 독성학 연구소 시장 전망 : 약제 클래스별, 금액(100만 달러)(2018-2030년)
북미의 독성학 연구소 시장 전망 : 제품 유형별, 금액(100만 달러)(2018-2030년)
북미의 독성학 연구소 시장 전망 : 샘플별, 금액(100만 달러)(2018-2030년)
북미의 독성학 연구소 시장 전망 : 국가별, 금액(100만 달러)(2018-2030년)

제4장 경쟁 구도

기업의 시장 점유율 분석(2022년)
주요 기업별 시장 집중
경쟁 대시보드
기업 프로파일
- Thermo Fisher Scientific
- Bio-Rad Laboratories, Inc.
- NEOGEN Corporation
- Redwood Toxicology Laboratory, Inc.
- Vala Sciences, Inc.
- Enzo Life Sciences, Inc.
- Alere, Inc.
- Agilent Technologies, Inc.
- Immunalysis Corporation
- Danaher Corporation
- Principle Diagnostics Laboratory
- Principle Laboratory
- Principle Diagnostics Laboratory
- Clinical Reference Laboratory, Inc.
- Medical Toxicology Laboratory, LLC
- NMS Labs
- BATTS Laboratories
- Total Toxicology
- Life Brite Labs.
- Product Safety Labs
- Lexar Labs

제5장 부록

AJY

영문 목차

영문목차

The North America toxicology laboratories market, unveiling promising forecasts and insightful trends driving the industry's evolution. With an impeccable Compound Annual Growth Rate (CAGR) of 10.4% projected during the forecast period, the market is expected to surge from US$255.2 million in 2023 to an estimated US$511.2 million by the end of 2030.

Rapid Screening Technologies: A Key Driver of Growth

The report highlights the increasing significance of rapid screening technologies as a primary trend propelling market expansion. With advancements in technologies such as Gas Chromatography-Mass Spectrometry (GC-MS), toxicology laboratories are witnessing a surge in demand for efficient screening methods, enhancing turnaround times and sensitivity.

Integration of Informatics and Data Solutions

Another pivotal trend identified in the report is the integration of informatics and data solutions within toxicology laboratories. Confidential test results are securely stored in mass spectral databases, emphasizing the importance of data integrity and confidentiality in the industry.

Key Segment Insights

Drug Class Dominance: Amphetamines emerge as the leading segment, capturing 17.9% of the market share and projected to grow at a robust CAGR of 11.0% during the forecast period.
Product Type Leadership: Reagent and kits claim the majority share of 61.6%, expected to grow at a steady CAGR of 9.7% over the forecast period.

Regulatory Frameworks Fueling Market Growth

The report underscores the role of robust regulatory frameworks in driving market growth across industries such as pharmaceuticals, cosmetics, food, and chemicals. Stricter regulations in the US and Canada mandate rigorous testing, creating a conducive environment for market expansion.

Challenges and Opportunities

While traditional toxicology laboratories face challenges from the introduction of point-of-care testing devices, increasing government spending on toxicity testing presents lucrative opportunities for market players. Collaborations between regulatory bodies and industry stakeholders further stimulate innovation and growth.

Competitive Analysis

Prominent organizations are spearheading the sector with innovative solutions and strategic alliances. Competitive intelligence and strategic decision-making remain crucial for companies navigating the dynamic landscape of the toxicology laboratories market.

Global North America Toxicology Laboratories Market:

Thermo Fisher Scientific, Inc.
Bio Rad Laboratories Inc.
Neogen Corporation
Danaher Corporation
Agilent
Redwood Toxicology Laboratory
Abbott (Alere, Inc.)

Global North America Toxicology Laboratories Market Is Segmented as Below:

Drug Class:

Alcohol
Amphetamines
Barbiturates
Benzodiazepines
Illicit Drugs
Opiates/Opioids
Tricyclic's Antidepressants
Z Drugs
Misc

Product Type:

Reagent Kits
- ELISA
- PCR
- Enzyme Multiplied Immunoassay Technique (EMIT)
- Radio Immuno-sorbent Assay (RIA)
Instruments
- Immunochemistry Analyzers
- PCR Machine
- Gas Chromatography/Mass Spectrometry (GS/MS)
- High Performance Liquid Chromatography (HPLC)

Sample:

Urine
Blood
Hair
Oral Fluid

End User:

Hospitals
Clinics
Diagnostic Laboratories
Forensic Laboratories
Rehabilitation Centers

By Geographic Coverage:

North America
- U.S.
- Canada

1. Executive Summary

1.1. North America Toxicology Laboratories Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. Covid-19 Impact Analysis
- 2.5.1. Overview
- 2.5.2. Impact By Region
2.6. Economic Overview
- 2.6.1. World Economic Projections
2.7. PESTLE Analysis

3. North America Toxicology Laboratories Market Outlook, 2018 - 2030

3.1. North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2030
- 3.1.1. Key Highlights
  - 3.1.1.1. Alcohol
  - 3.1.1.2. Amphetamines
  - 3.1.1.3. Barbiturates
  - 3.1.1.4. Benzodiazepines
  - 3.1.1.5. Illicit Drugs
  - 3.1.1.6. Opiates/Opioids
  - 3.1.1.7. Tricyclic's Antidepressants
  - 3.1.1.8. Z Drugs
  - 3.1.1.9. Others
3.2. North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030
- 3.2.1. Key Highlights
  - 3.2.1.1. Reagent Kits
    - 3.2.1.1.1. ELISA
    - 3.2.1.1.2. PCR
    - 3.2.1.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
    - 3.2.1.1.4. Radio Immuno-sorbent Assay (RIA)
  - 3.2.1.2. Instruments
    - 3.2.1.2.1. Immunochemistry Analyzers
    - 3.2.1.2.2. PCR Machine
    - 3.2.1.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
    - 3.2.1.2.4. High Performance Liquid Chromatography (HPLC)
3.3. North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2018 - 2030
- 3.3.1. Key Highlights
  - 3.3.1.1. Urine
  - 3.3.1.2. Blood
  - 3.3.1.3. Hair
  - 3.3.1.4. Oral Fluid
- 3.3.2. Market Attractiveness Analysis
3.4. North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
- 3.4.1. Key Highlights
  - 3.4.1.1. U.S. Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 - 2030
  - 3.4.1.2. U.S. Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 - 2030
  - 3.4.1.3. U.S. Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 - 2030
  - 3.4.1.4. Canada Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 - 2030
  - 3.4.1.5. Canada Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 - 2030
  - 3.4.1.6. Canada Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 - 2030
- 3.4.2. Market Attractiveness Analysis

4. Competitive Landscape

4.1. Company Market Share Analysis, 2022
4.2. Market Concentration by Top Players
4.3. Competitive Dashboard
4.4. Company Profiles
- 4.4.1. Thermo Fisher Scientific
  - 4.4.1.1. Company Overview
  - 4.4.1.2. Product Portfolio
  - 4.4.1.3. Financial Overview
  - 4.4.1.4. Business Strategies and Development
- 4.4.2. Bio-Rad Laboratories, Inc.
  - 4.4.2.1. Company Overview
  - 4.4.2.2. Product Portfolio
  - 4.4.2.3. Financial Overview
  - 4.4.2.4. Business Strategies and Development
- 4.4.3. NEOGEN Corporation
  - 4.4.3.1. Company Overview
  - 4.4.3.2. Product Portfolio
  - 4.4.3.3. Financial Overview
  - 4.4.3.4. Business Strategies and Development
- 4.4.4. Redwood Toxicology Laboratory, Inc.
  - 4.4.4.1. Company Overview
  - 4.4.4.2. Product Portfolio
  - 4.4.4.3. Financial Overview
  - 4.4.4.4. Business Strategies and Development
- 4.4.5. Vala Sciences, Inc.
  - 4.4.5.1. Company Overview
  - 4.4.5.2. Product Portfolio
  - 4.4.5.3. Financial Overview
  - 4.4.5.4. Business Strategies and Development
- 4.4.6. Enzo Life Sciences, Inc.
  - 4.4.6.1. Company Overview
  - 4.4.6.2. Product Portfolio
  - 4.4.6.3. Financial Overview
  - 4.4.6.4. Business Strategies and Development
- 4.4.7. Alere, Inc.
  - 4.4.7.1. Company Overview
  - 4.4.7.2. Product Portfolio
  - 4.4.7.3. Financial Overview
  - 4.4.7.4. Business Strategies and Development
- 4.4.8. Agilent Technologies, Inc.
  - 4.4.8.1. Company Overview
  - 4.4.8.2. Product Portfolio
  - 4.4.8.3. Financial Overview
  - 4.4.8.4. Business Strategies and Development
- 4.4.9. Immunalysis Corporation
  - 4.4.9.1. Company Overview
  - 4.4.9.2. Product Portfolio
  - 4.4.9.3. Financial Overview
  - 4.4.9.4. Business Strategies and Development
- 4.4.10. Danaher Corporation
  - 4.4.10.1. Company Overview
  - 4.4.10.2. Product Portfolio
  - 4.4.10.3. Financial Overview
  - 4.4.10.4. Business Strategies and Development
- 4.4.11. Principle Diagnostics Laboratory
  - 4.4.11.1. Company Overview
  - 4.4.11.2. Product Portfolio
  - 4.4.11.3. Financial Overview
  - 4.4.11.4. Business Strategies and Development
- 4.4.12. Principle Laboratory
  - 4.4.12.1. Company Overview
  - 4.4.12.2. Product Portfolio
  - 4.4.12.3. Financial Overview
  - 4.4.12.4. Business Strategies and Development
- 4.4.13. Principle Diagnostics Laboratory
  - 4.4.13.1. Company Overview
  - 4.4.13.2. Product Portfolio
  - 4.4.13.3. Financial Overview
  - 4.4.13.4. Business Strategies and Development
- 4.4.14. Clinical Reference Laboratory, Inc.
  - 4.4.14.1. Company Overview
  - 4.4.14.2. Product Portfolio
  - 4.4.14.3. Financial Overview
  - 4.4.14.4. Business Strategies and Development
- 4.4.15. Medical Toxicology Laboratory, LLC
  - 4.4.15.1. Company Overview
  - 4.4.15.2. Product Portfolio
  - 4.4.15.3. Financial Overview
  - 4.4.15.4. Business Strategies and Development
- 4.4.16. NMS Labs
  - 4.4.16.1. Company Overview
  - 4.4.16.2. Product Portfolio
  - 4.4.16.3. Financial Overview
  - 4.4.16.4. Business Strategies and Development
- 4.4.17. BATTS Laboratories
  - 4.4.17.1. Company Overview
  - 4.4.17.2. Product Portfolio
  - 4.4.17.3. Financial Overview
  - 4.4.17.4. Business Strategies and Development
- 4.4.18. Total Toxicology
  - 4.4.18.1. Company Overview
  - 4.4.18.2. Product Portfolio
  - 4.4.18.3. Financial Overview
  - 4.4.18.4. Business Strategies and Development
- 4.4.19. Life Brite Labs.
  - 4.4.19.1. Company Overview
  - 4.4.19.2. Product Portfolio
  - 4.4.19.3. Financial Overview
  - 4.4.19.4. Business Strategies and Development
- 4.4.20. Product Safety Labs
  - 4.4.20.1. Company Overview
  - 4.4.20.2. Product Portfolio
  - 4.4.20.3. Financial Overview
  - 4.4.20.4. Business Strategies and Development
- 4.4.21. Lexar Labs
  - 4.4.21.1. Company Overview
  - 4.4.21.2. Product Portfolio
  - 4.4.21.3. Financial Overview
  - 4.4.21.4. Business Strategies and Development

5. Appendix

5.1. Research Methodology
5.2. Report Assumptions
5.3. Acronyms and Abbreviations